Shionogi Enters Growing Pool Of Japanese Firms Developing Hay Fever Therapies
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Shionogi has signed an exclusive partnership with French firm Stallergenes for two sublingual allergy products, joining the ranks of Japanese biotech firms hoping to tap into Japan's hay fever market
You may also be interested in...
Shionogi Spurns Europe, Places Bets On Asia For Global Expansion - Bio Expo Japan
TOKYO - Shionogi, set on global expansion, has rejected initial plans to expand into Europe, instead turning to emerging markets in Asia
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).